Koyfin Home > Directory > Health Care > Amphastar Pharma > EBITDA Margin

Amphastar Pharma EBITDA Margin Chart (AMPH)

Amphastar Pharma annual/quarterly EBITDA Margin from 2014 to 2018. An EBITDA margin is a measurement of a company's earnings before interest, taxes, depreciation, and amortization as a percentage of its total revenue.
  • Amphastar Pharma EBITDA Margin for the quarter ending December 12, 2018 was $6m a 248.20% increase of 16m year over year
  • Amphastar Pharma EBITDA Margin for the last 12 months ending December 12, 2018 was $3m a 37.87% increase of 1m year over year
  • Amphastar Pharma Annual EBITDA Margin for 2018 was $3m a -91.79% decrease of -2m from 2017
  • Amphastar Pharma Annual EBITDA Margin for 2017 was $5m a -144.22% decrease of -7m from 2016
  • Amphastar Pharma Annual EBITDA Margin for 2016 was $12m a 68.05% increase of 8m from 2015
Other Margins & Efficiency Metrics:
  • Amphastar Pharma Return on Capital % for the quarter ending December 12, 2018 was 0.96 a 742.79% increase of 7.11 year over year
  • Amphastar Pharma Return on Equity % for the quarter ending December 12, 2018 was 1.95 a 547.96% increase of 10.67 year over year
View Chart On Koyfin

Quarterly AMPH EBITDA Margin Data

12/2018$6m
09/2018$9m
06/2018$2m
03/2018$-9m
12/2017$4m
09/2017$2m
06/2017$9m
03/2017$5m
12/2016$-1m
09/2016$15m

Annual AMPH EBITDA Margin Data

2018$3m
2017$5m
2016$12m
2015$4m
2014$-2m
2013$13m